SCHEMBL21808817

SCHEMBL21808817

Brc1ccc(-c2cc(-c3cccc(-c4ccccc4)c3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.57
▸ KMT2A Q03164 7/20 0.57
▸ ALDH1A1 P00352 7/20 0.57
▸ MAPT P10636 6/20 0.57
▸ HPGD P15428 5/20 0.57
▸ KDM4E B2RXH2 4/20 0.57
▸ LMNA P02545 2/20 0.57
▸ GLA P06280 1/20 0.57
▸ AGTR1 P30556 1/20 0.57
▸ NTSR1 P30989 1/20 0.56
▸ MCL1 Q07820 3/20 0.53
▸ MAPK1 P28482 1/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ NFKB1 P19838 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ NFKB2 Q00653 1/20 0.51
▸ RELA Q04206 1/20 0.51
▸ NR1H4 Q96RI1 1/20 0.49
▸ ADORA2A P29274 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23197477 1.00 MEN1 (0.57) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22534581 1.00 MEN1 (0.57) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL29714732 1.00 MEN1 (0.57) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL30400680 1.00 MEN1 (0.57) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22913722 1.00 MEN1 (0.57) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22914329 0.98 AGTR1 (0.58) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL19383112 0.98 ALDH1A1 (0.54) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL15458583 0.98 AGTR1 (0.58) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL22092462 0.95 AGTR1 (0.58) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL31190081 0.95 AGTR1 (0.58) MEN1KMT2AALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111406057-B Heterocyclic compound and organic light-emitting device comprising same LT素材株式会社 2023-04-18 — — CN disclosed
US-20230013934-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-01-19 — — US disclosed
US-11472817-B2 Heterocyclic compound and organic light-emitting device comprising same LT MATERIALS CO., LTD. (KR) 2022-10-18 — — US disclosed
EP-4015515-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2022-06-22 — — EP disclosed
US-20220024948-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2022-01-27 — — US disclosed
WO-2021066397-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 엘티소재주식회사 2021-04-08 — — WO disclosed
WO-2021034039-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 엘티소재주식회사 2021-02-25 — — WO disclosed
WO-2021015497-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME 엘티소재주식회사 2021-01-28 — — WO disclosed
US-20200255452-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2020-08-13 — — US disclosed
CN-111406057-A Heterocyclic compound and organic light-emitting device comprising same LT素材株式会社 2020-07-10 — — CN disclosed
WO-2020060225-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 엘티소재주식회사 2020-03-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220024948-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 MEN1 344/4885KMT2A 788/4885ALDH1A1 9/4885
US-20200255452-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 MEN1 257/4885KMT2A 758/4885ALDH1A1 9/4885
US-20230013934-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME CRY1, CYP1B1, CYP1A1 MEN1 700/4885KMT2A 656/4885ALDH1A1 6/4885
US-11472817-B2 Heterocyclic compound and organic light-emitting device comprising same CRY1, CYP1A1, CYP1B1 MEN1 257/4885KMT2A 758/4885ALDH1A1 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback